CCPortal

浏览/检索结果: 共2条,第1-2条 帮助

已选(0)清除 条数/页:   排序方式:
Number of HIV-1 founder variants is determined by the recency of the source partner infection 期刊论文
, 2020, 卷号: 369, 期号: 6499
作者:  Villabona-Arenas C.J.;  Hall M.;  Lythgoe K.A.;  Gaffney S.G.;  Regoes R.R.;  Hué S.;  Atkins K.E.
收藏  |  浏览/下载:28/0  |  提交时间:2020/07/28
classification  founder effect  genetic variation  genetics  human  Human immunodeficiency virus 1  Human immunodeficiency virus infection  phylogeny  sexuality  virology  virus load  Founder Effect  Genetic Variation  HIV Infections  HIV-1  Humans  Phylogeny  Sexual Partners  Viral Load  
Structural basis for strand-transfer inhibitor binding to HIV intasomes 期刊论文
, 2020, 卷号: 367, 期号: 6479
作者:  Passos D.O.;  Li M.;  Jóźwik I.K.;  Zhao X.Z.;  Santos-Martins D.;  Yang R.;  Smith S.J.;  Jeon Y.;  Forli S.;  Hughes S.H.;  Burke T.R.;  Jr.;  Craigie R.;  Lyumkis D.
收藏  |  浏览/下载:19/0  |  提交时间:2020/07/28
bictegravir  nucleoprotein  protein intasome  unclassified drug  viral protein  bictegravir  fused heterocyclic rings  integrase  integrase inhibitor  multiprotein complex  naphthyridine derivative  nucleoprotein  biochemistry  chemical binding  human immunodeficiency virus  inhibitor  protein  ultrastructure  amino terminal sequence  Article  carboxy terminal sequence  catalysis  cryoelectron microscopy  drug design  drug efficacy  drug protein binding  drug resistance  drug structure  enzyme active site  human  Human immunodeficiency virus infection  nonhuman  priority journal  protein purification  protein structure  antiviral resistance  chemistry  drug effect  genetics  Human immunodeficiency virus  virus DNA cell DNA interaction  Cryoelectron Microscopy  Drug Design  Drug Resistance, Viral  Heterocyclic Compounds, 4 or More Rings  HIV  HIV Integrase  HIV Integrase Inhibitors  Humans  Multiprotein Complexes  Naphthyridines  Nucleoproteins  Virus Integration